Diagnostics News and Research

RSS

Chiron announces settlement with Roche in HIV patent dispute

Chiron Corporation has announced that it has reached a settlement with F. Hoffmann-La Roche (Roche) in a dispute over licensing fees and royalties that Chiron had asserted was owed to the company under a licensing agreement related to its U.S. Patent No. 6,531,276 (the "276 Patent").

12 Sep 2004

University of Utah gets patent approval relating to methods of rapid nucleic acid amplification

The U.S. Patent and Trademark Office has issued the University of Utah U.S. patent No. U.S. 6,787,338 (the '338 patent) relating to methods of rapid nucleic acid amplification.

8 Sep 2004

Lack of sleep may cause behavioral, learning and attention problems

Nine-year-old Fernando Perry-Mendoza may no longer need medication for attention-deficit/hyperactivity disorder thanks to the results of a sleep study at Doernbecher Children’s Hospital’s new Pediatric Sleep Program.

1 Sep 2004

Antibodies produced by shark immune systems could be used to detect human pathogens

A recent discovery shows that antibodies produced by shark immune systems could be used to detect a range of human pathogens some of which have the potential to be used as biological warfare agents.

20 Aug 2004

Successful resuscitation rates doubled after upgrade to automated external defibrillators

Successful resuscitation rates more than doubled after the Atlanta VA Medical Center instituted a program of upgrading existing defibrillators and placing automated external defibrillators (AEDs) throughout the hospital, while also educating staff, according to a new study in the Aug. 18, 2004 issue of the Journal of the American College of Cardiology.

18 Aug 2004

Not all good cholesterol helps to protect arteries from becoming clogged with fatty deposits

HDL becomes dysfunctional, Dr. Hazen said, when myeloperoxidase (MPO), an enzyme present in white blood cells, inhibits the HDL's ability to keep LDL, or "bad" cholesterol, from building up in artery walls.

17 Aug 2004

Finnish company discovers over 200 new genes

Finnish company Jurilab has announced the completion of a genome-wide scan in Acute Myocardial Infarction in the East Finland Founder Population.

12 Aug 2004

Free licences of European patents on the hereditary breast cancer gene BRCA2

The Institute of Cancer Research and Cancer Research Technology Limited, the technology transfer company of the charity Cancer Research UK, today announced the availability of free licences of European patents on the hereditary breast cancer gene BRCA2 to publicly funded research laboratories and not-for-profit research laboratories.

11 Aug 2004

Potential of genomics in disease research yet to be realized

Over the past decade genomics has revolutionized our understanding of how microorganisms cause disease. However, genomic studies need to be extended to a more diverse array of microorganisms and research tools improved to gain additional insights into pathogenesis, according to a new report released by the American Academy of Microbiology.

5 Aug 2004

PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures

A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.

5 Aug 2004

ATS receives US $10.7 million in orders from one of the world's largest medical device companies

ATS Automation Tooling Systems has announced it has recently received a total of US $10.7 million (CDN $14.2 million) in orders from one of the world's largest manufacturers of self-use medical diagnostic systems.

5 Aug 2004

Cancer detection kit, which fuses molecular diagnostics with nanotechnology

Acrongenomics Inc. has introduced a revolutionary design of its nanobiotechnology product, the Neo-EpCAM(TM) cancer detection kit, which fuses molecular diagnostics with nanotechnology.

29 Jul 2004

New process that simplifies the production of proteins

F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.

29 Jul 2004

Emerging nanomedicine technologies could dramatically transform medical science

Emerging nanomedicine technologies could dramatically transform medical science as we know it today with their potential to address unmet medical needs and provide targeted therapy.

23 Jul 2004

European launch of non-invasive, painless and radiation-free device for the diagnosis of internal organ diseases

Medex Screen Ltd. today announced the European launch of MedexTest - a revolutionary non-invasive, painless and radiation-free device for the diagnosis of internal organ diseases (cardiovascular system, endocrine systems, immune system, urogenital organs, digestive system, respiratory system, spine etc.).

22 Jul 2004

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.

21 Jul 2004

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines and diagnostic tools suited to children, claimed Médecins Sans Frontières at the XV International AIDS Conference in Bangkok.

15 Jul 2004

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Prostate cancer is much more likely to be aggressive if a key protein called Stat5 is found activated and in abundance in the cancer cells, report researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

15 Jul 2004

Quality HIV/AIDS treatment eased through extended agreement about lowest-priced drugs and diagnostics

During the International AIDS Conference in Bangkok, IDA ARV Procurement Services BV and Clinton Foundation announced the agreement that enables developing countries to purchase high-quality AIDS medicines and diagnostics at the lowest available prices.

15 Jul 2004

HIV patients treated with antiretroviral therapy early after infection do test negative

UCSF researchers have found that some HIV patients treated with antiretroviral therapy early after infection do test negative, at some point, for the virus. Study findings showed this result in six of 87 patients.

12 Jul 2004

Diagnostics News and Research

Chiron announces settlement with Roche in HIV patent dispute

University of Utah gets patent approval relating to methods of rapid nucleic acid amplification

Lack of sleep may cause behavioral, learning and attention problems

Antibodies produced by shark immune systems could be used to detect human pathogens

Successful resuscitation rates doubled after upgrade to automated external defibrillators

Not all good cholesterol helps to protect arteries from becoming clogged with fatty deposits

Finnish company discovers over 200 new genes

Free licences of European patents on the hereditary breast cancer gene BRCA2

Potential of genomics in disease research yet to be realized

PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures

ATS receives US $10.7 million in orders from one of the world's largest medical device companies

Cancer detection kit, which fuses molecular diagnostics with nanotechnology

New process that simplifies the production of proteins

Emerging nanomedicine technologies could dramatically transform medical science

European launch of non-invasive, painless and radiation-free device for the diagnosis of internal organ diseases

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Quality HIV/AIDS treatment eased through extended agreement about lowest-priced drugs and diagnostics

HIV patients treated with antiretroviral therapy early after infection do test negative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News